CIK 0001835579 · <br>Emerging growth company
ImageneBio, Inc.
Sign in to watch- Ticker
- IMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811697316
- Phone
- 857-343-8292
- Business address
- 12526 HIGH BLUFF DRIVE, SAN DIEGO, CA, 92130
- Former names
- Ikena Oncology, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | Germa Caroline Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +579,100 | 579,100 | ||
| 2024-02-01 | Ecsedy Jeffrey Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-02-01 | Marango Jotin CFO & Head of Corp. Dev. | Grant or award · Stock Option (Right to Buy) | +181,000 | 181,000 | ||
| 2024-02-01 | Manfredi Mark President & CEO | Grant or award · Stock Option (Right to Buy) | +320,000 | 320,000 | ||
| 2023-08-04 | Bonita David P Director | Grant or award | +153,121 | 5,582,144 | ||
| 2023-08-04 | Bonita David P Director | Grant or award · Series A Preferred Stock | +353,192 | 353,192 | ||
| 2023-08-04 | ORBIMED ADVISORS LLC Director | Grant or award | +153,121 | 5,582,144 | ||
| 2023-08-04 | ORBIMED ADVISORS LLC Director | Grant or award · Series A Preferred Stock | +353,192 | 353,192 | ||
| 2023-08-04 | ORBIMED ADVISORS LLC Director | Grant or award | +153,121 | 2,251,218 | ||
| 2023-08-04 | ORBIMED ADVISORS LLC Director | Grant or award · Series A Preferred Stock | +353,192 | 353,192 | ||
| 2023-08-04 | Bonita David P Director | Grant or award | +153,121 | 2,251,218 | ||
| 2023-08-04 | Bonita David P Director | Grant or award · Series A Preferred Stock | +353,192 | 353,192 | ||
| 2023-06-09 | Koehler Maria Director | Grant or award · Stock Option (Right to Buy) | +17,520 | 17,520 | ||
| 2023-06-09 | Dukes Iain D. Director | Grant or award · Stock Option (Right to Buy) | +17,520 | 17,520 | ||
| 2023-06-09 | Hughes Owen Director | Grant or award · Stock Option (Right to Buy) | +17,520 | 17,520 | ||
| 2023-06-09 | Bonita David P Director | Grant or award · Stock Option (Right to Buy) | +17,520 | 17,520 | ||
| 2023-06-09 | Stampacchia Otello Director | Grant or award · Stock Option (Right to Buy) | +17,520 | 17,520 | ||
| 2023-06-09 | FORMELA JEAN FRANCOIS Director | Grant or award · Stock Option (Right to Buy) | +17,520 | 17,520 | ||
| 2023-06-09 | Wooster Richard Director | Grant or award · Stock Option (Right to Buy) | +17,520 | 17,520 | ||
| 2023-01-03 | Santillana Sergio L. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 |
Page 4 of 12 · 222 trades